Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21
- PMID: 29743610
- PMCID: PMC5943590
- DOI: 10.1038/s41598-018-24580-z
Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21
Abstract
Incidence of glioma is approximately 50% higher in males. Previous analyses have examined exposures related to sex hormones in women as potential protective factors for these tumors, with inconsistent results. Previous glioma genome-wide association studies (GWAS) have not stratified by sex. Potential sex-specific genetic effects were assessed in autosomal SNPs and sex chromosome variants for all glioma, GBM and non-GBM patients using data from four previous glioma GWAS. Datasets were analyzed using sex-stratified logistic regression models and combined using meta-analysis. There were 4,831 male cases, 5,216 male controls, 3,206 female cases and 5,470 female controls. A significant association was detected at rs11979158 (7p11.2) in males only. Association at rs55705857 (8q24.21) was stronger in females than in males. A large region on 3p21.31 was identified with significant association in females only. The identified differences in effect of risk variants do not fully explain the observed incidence difference in glioma by sex.
Conflict of interest statement
This study was approved locally by the institutional review board (IRB) at University Hospitals Cleveland Medical Center and by each participating study site’s IRB. Written informed consent was obtained from all participants. There are no conflicts of interest to report. The GliomaScan (phs000652.v1.p1), CGEMS (phs000812.v1.p1), San Francisco Adult Glioma Study (phs001497.v1.p1), and GICC (phs001319.v1.p1) data used for these analyses are available through dbGap. Individual genotypes and phenotypes from the MD Anderson Glioma GWAS are being submitted to dbGAP, and final identifiers to these data will be provided in the final manuscript. The results here are in part based upon data generated by the TCGA Research Network: (
Figures






Similar articles
-
The association of 6 variants of 8q24 and the risk of glioma: A meta-analysis.Medicine (Baltimore). 2019 Jul;98(27):e16205. doi: 10.1097/MD.0000000000016205. Medicine (Baltimore). 2019. PMID: 31277128 Free PMC article. Review.
-
Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.Int J Cancer. 2018 Nov 15;143(10):2359-2366. doi: 10.1002/ijc.31759. Epub 2018 Sep 19. Int J Cancer. 2018. PMID: 30152087 Free PMC article.
-
Deciphering the 8q24.21 association for glioma.Hum Mol Genet. 2013 Jun 1;22(11):2293-302. doi: 10.1093/hmg/ddt063. Epub 2013 Feb 11. Hum Mol Genet. 2013. PMID: 23399484 Free PMC article.
-
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.Neuro Oncol. 2023 Jul 6;25(7):1355-1365. doi: 10.1093/neuonc/noac279. Neuro Oncol. 2023. PMID: 36541697 Free PMC article.
-
Genome-Wide Association Studies in Glioma.Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):418-428. doi: 10.1158/1055-9965.EPI-17-1080. Epub 2018 Jan 30. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29382702 Free PMC article. Review.
Cited by
-
Drug resistance in glioblastoma: from chemo- to immunotherapy.Cancer Drug Resist. 2023 Oct 11;6(4):688-708. doi: 10.20517/cdr.2023.82. eCollection 2023. Cancer Drug Resist. 2023. PMID: 38239396 Free PMC article. Review.
-
Sex-Specific Differences in Glioblastoma.Cells. 2021 Jul 14;10(7):1783. doi: 10.3390/cells10071783. Cells. 2021. PMID: 34359952 Free PMC article. Review.
-
Sex-Specific Differences in Patients with IDH1-Wild-Type Grade 4 Glioma in the ReSPOND Consortium.AJNR Am J Neuroradiol. 2024 Sep 9;45(9):1299-1307. doi: 10.3174/ajnr.A8319. AJNR Am J Neuroradiol. 2024. PMID: 38684319
-
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.Gastroenterology. 2020 Dec;159(6):2065-2076.e1. doi: 10.1053/j.gastro.2020.08.052. Epub 2020 Sep 9. Gastroenterology. 2020. PMID: 32918910 Free PMC article.
-
LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma.Oncol Rep. 2019 May;41(5):2753-2761. doi: 10.3892/or.2019.7065. Epub 2019 Mar 14. Oncol Rep. 2019. PMID: 30896861 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
- R01 CA139020/CA/NCI NIH HHS/United States
- HHSN261201000140C/CA/NCI NIH HHS/United States
- R01 CA126831/CA/NCI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- P30 CA125123/CA/NCI NIH HHS/United States
- P50 CA097257/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- R01 CA207360/CA/NCI NIH HHS/United States
- R01 CA052689/CA/NCI NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- U58 DP003862/DP/NCCDPHP CDC HHS/United States
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources